Is it metastatic melanoma or is it sarcoidosis? Non-caseating granulomas due to pembrolizumab.
作者信息
Chahin Michael, Stack Anthony, Siddiqi Anwer, Shaikh Marwan
机构信息
Internal Medicine, University of Florida College of Medicine - Jacksonville, Jacksonville, Florida, USA
Internal Medicine, University of Florida College of Medicine - Jacksonville, Jacksonville, Florida, USA.
出版信息
BMJ Case Rep. 2020 Dec 22;13(12):e240701. doi: 10.1136/bcr-2020-240701.
Abstract
摘要
相似文献
1
Is it metastatic melanoma or is it sarcoidosis? Non-caseating granulomas due to pembrolizumab.
BMJ Case Rep. 2020 Dec 22;13(12):e240701. doi: 10.1136/bcr-2020-240701.
2
Multiple "halo nevi" occurring during pembrolizumab treatment for metastatic melanoma.
Int J Dermatol. 2019 Jun;58(6):739-741. doi: 10.1111/ijd.14239. Epub 2018 Sep 19.
3
Pembrolizumab as a Cause of Cholangiopathy in a Patient With Metastatic Melanoma.
Hepatology. 2020 Jun;71(6):2164-2166. doi: 10.1002/hep.31089.
4
Checkpoint inhibitor-induced sarcoid reaction mimicking bone metastases.
Lancet Oncol. 2018 Jun;19(6):e327. doi: 10.1016/S1470-2045(18)30252-3. Epub 2018 Jun 1.
5
Sarcoidosis post-anti-PD-1 therapy, mimicking relapse of metastatic melanoma in a patient undergoing complete remission.
Rev Med Interne. 2018 Feb;39(2):130-133. doi: 10.1016/j.revmed.2017.11.008. Epub 2017 Dec 23.
6
Rare immune-related adverse events in a patient with metastatic melanoma: a case report highlighting sarcoidosis-like reactions triggered by immune-checkpoint inhibitors.
Melanoma Res. 2024 Feb 1;34(1):70-75. doi: 10.1097/CMR.0000000000000925. Epub 2023 Oct 13.
7
Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: Increased rate and mimicker of metastasis.
Eur J Cancer. 2020 May;131:18-26. doi: 10.1016/j.ejca.2020.02.024. Epub 2020 Apr 2.
8
Delayed Pembrolizumab-Associated Sarcoidosis.
Am J Ther. 2024;31(4):e465-e468. doi: 10.1097/MJT.0000000000001674.
9
Sarcoidosis-like syndrome and lymphadenopathy due to checkpoint inhibitors.
J Oncol Pharm Pract. 2017 Dec;23(8):620-624. doi: 10.1177/1078155216667635. Epub 2016 Sep 2.
10
FDG PET/CT Course of Pembrolizumab-Associated Multiorgan Sarcoidosis.
Clin Nucl Med. 2019 Feb;44(2):167-168. doi: 10.1097/RLU.0000000000002408.
引用本文的文献
1
Drug-Induced Sarcoid-like Reactions Associated to Targeted Therapies and Biologic Agents.
Diagnostics (Basel). 2025 Jun 29;15(13):1658. doi: 10.3390/diagnostics15131658.
2
Suspected immune checkpoint inhibitor-induced pulmonary sarcoid reaction in metastatic renal cell carcinoma.
Clin Case Rep. 2022 Jul 11;10(7):e5960. doi: 10.1002/ccr3.5960. eCollection 2022 Jul.
3
Sarcoid-like Granulomatosis Associated with Immune Checkpoint Inhibitors in Melanoma.
Cancers (Basel). 2022 Jun 14;14(12):2937. doi: 10.3390/cancers14122937.
本文引用的文献
1
Adverse Effects of Immune Checkpoint Inhibitors (Programmed Death-1 Inhibitors and Cytotoxic T-Lymphocyte-Associated Protein-4 Inhibitors): Results of a Retrospective Study.
J Clin Med Res. 2019 Apr;11(4):225-236. doi: 10.14740/jocmr3750. Epub 2019 Mar 18.
2
Sarcoidosis-Like Reactions Induced by Checkpoint Inhibitors.
J Thorac Oncol. 2018 Aug;13(8):1076-1082. doi: 10.1016/j.jtho.2018.04.031. Epub 2018 May 12.
3
Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients.
J Immunother Cancer. 2018 Feb 12;6(1):14. doi: 10.1186/s40425-018-0323-0.
Zotero 插件